Ekberg H - Search Results

1

A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation.

Tydén G, Genberg H, Tollemar J, Ekberg H, Persson NH, Tufveson G, Wadström J, Gäbel M, Mjörnstedt L. Tydén G, et al. Among authors: ekberg h. Transplantation. 2009 May 15;87(9):1325-9. doi: 10.1097/TP.0b013e3181a235fd. Transplantation. 2009. PMID: 19424032 Clinical Trial.

2

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up.

Tydén G, Ekberg H, Tufveson G, Mjörnstedt L. Tydén G, et al. Among authors: ekberg h. Transplantation. 2012 Aug 15;94(3):e21-2. doi: 10.1097/01.tp.0000418580.88642.e1. Transplantation. 2012. PMID: 22872297 Clinical Trial. No abstract available.

3

Triple versus quadruple induction immunosuppression in pancreas transplantation.

Wadström J, Brekke B, Wramner L, Ekberg H, Tydén G. Wadström J, et al. Among authors: ekberg h. Transplant Proc. 1995 Feb;27(1):1317-8. Transplant Proc. 1995. PMID: 7878896 Clinical Trial. No abstract available.

4

Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups.

Ekberg H, Bäckman L, Tufveson G, Tydén G. Ekberg H, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):267-8. doi: 10.1016/s0041-1345(98)01529-2. Transplant Proc. 1999. PMID: 10083102 Clinical Trial. No abstract available.

5

Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.

Ekberg H, Bernasconi C, Nöldeke J, Yussim A, Mjörnstedt L, Erken U, Ketteler M, Navrátil P. Ekberg H, et al. Nephrol Dial Transplant. 2010 Jun;25(6):2004-10. doi: 10.1093/ndt/gfp778. Epub 2010 Jan 26. Nephrol Dial Transplant. 2010. PMID: 20106825 Clinical Trial.

6

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation.

Ekberg J, Ekberg H, Jespersen B, Källen R, Skov K, Olausson M, Mjörnstedt L, Lindnér P. Ekberg J, et al. Among authors: ekberg h. Transplant Res. 2014 Jun 13;3:12. doi: 10.1186/2047-1440-3-12. eCollection 2014. Transplant Res. 2014. PMID: 24959347 Free PMC article.

7

Kidneys from marginal donors: views of patients on informed consent.

Persson MO, Persson NH, Källén R, Ekberg H, Hermerén G. Persson MO, et al. Among authors: ekberg h. Nephrol Dial Transplant. 2002 Aug;17(8):1497-502. doi: 10.1093/ndt/17.8.1497. Nephrol Dial Transplant. 2002. PMID: 12147801

8

Flow cytometric measurements in 104 anti-T-lymphocyte globulin treatments.

Ekberg H, Persson NH, Olsson M, Lundell A, Bredberg A. Ekberg H, et al. Transplant Proc. 1992 Dec;24(6):2551-2. Transplant Proc. 1992. PMID: 1465863 No abstract available.

9

Evolution of pancreatic transplantation in Sweden.

Tydén G, Groth CG, Nyberg G, Olausson M, Wahlberg J, Wadström J, Persson N, Ekberg H. Tydén G, et al. Among authors: ekberg h. Transplant Proc. 1992 Feb;24(1):347-8. Transplant Proc. 1992. PMID: 1539310 No abstract available.

10

Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting.

Gannedahl G, Wanders A, Wadström J, Olausson M, Ekberg H, Tufveson G. Gannedahl G, et al. Among authors: ekberg h. Transplant Proc. 1994 Dec;26(6):3108-10. Transplant Proc. 1994. PMID: 7998085 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page